SCHEMBL6611136

SCHEMBL6611136

CCOC(=O)C1=C2C1=COc1ccccc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 13/20 0.46
MEN1 O00255 8/20 0.45
KMT2A Q03164 8/20 0.45
MAPT P10636 9/20 0.45
LMNA P02545 7/20 0.45
NPSR1 Q6W5P4 5/20 0.45
HPGD P15428 5/20 0.45
TDP1 Q9NUW8 4/20 0.45
SMN1; SMN2 Q16637 4/20 0.45
HTT P42858 3/20 0.45
ALOX12 P18054 3/20 0.45
PKM P14618 2/20 0.45
STAT3 P40763 1/20 0.45
KCNH2 Q12809 1/20 0.45
TSHR P16473 1/20 0.44
KDM4E B2RXH2 5/20 0.43
HKDC1 Q2TB90 4/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
GLA P06280 2/20 0.43
HSP90AA1 P07900 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1478444 0.77 FGFR1 (0.40) ALDH1A1MEN1KMT2AMAPTLMNA
SCHEMBL7201067 0.71 TSHR (0.50) ALDH1A1MEN1KMT2AMAPTLMNA
SCHEMBL9378392 0.69 MAPT (0.46) ALDH1A1MEN1KMT2AMAPTLMNA
SCHEMBL7487263 0.68 ALDH1A1 (0.47) ALDH1A1MEN1KMT2AMAPTLMNA
SCHEMBL6536971 0.67 TSHR (0.53) ALDH1A1MEN1KMT2AMAPTLMNA
SCHEMBL14000090 0.67 TSHR (0.49) ALDH1A1MEN1KMT2AMAPTLMNA
SCHEMBL29351770 0.67 TSHR (0.45) ALDH1A1MEN1KMT2AMAPTHPGD
SCHEMBL4537383 0.67 TSHR (0.45) ALDH1A1MEN1KMT2AMAPTHPGD
SCHEMBL9904567 0.66 MAPT (0.78) ALDH1A1MEN1KMT2AMAPTLMNA
SCHEMBL29617021 0.66 TSHR (0.80) ALDH1A1MEN1KMT2AMAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1373261-A2 CYCLOPROPAHETEROCYCLES AS NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS MEDIVIR AB (SE) 2004-01-02 EP disclosed
WO-2002070516-A2 CYCLOPROPAHETEROCYCLES AS NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS MEDIVIR AB (SE) 2002-09-12 WO disclosed